The risk of hepatitis C virus transmission after an exposure to blood shoul
d be considered in each situation. Serologic status of the patient source i
s evaluated A follow-up with dosage of anti-HCV antibodies and ALT is initi
ated when the serologic HCV status of the patient source is positive or unk
nown. There is no prophylactic treatment for hepatitis C with current antiv
iral drugs. Nevertheless, in case of acute hepatitis, an early treatment wi
th one or two drugs is established in a specialized setting, The follow-up
lasts six months. (C) Editions scientifiques et medicales Elsevier SAS.